Cornelius-based Balance Pharma has raised more than $2M

CORNELIUS – Balanced Pharma Inc., a Cornelius-based startup, has raised more than $2 million in equity financing, according to an updated and amended SEC filing.

The firm, which according to its website aims to revolutionize “medical and dental injections for a better patient experience,” disclosed in the filing that it had raised a total of $2,011,300 with participation from 44 investors, since December 16, 2020, the date of the first sale.

The company was formed in 2018 and is led by John Scott Keadle, the company’s chief executive, according to the filing.

Keadle, a licensed dentist who opened a dental practice in 1989 that is now based in Mooresville, North Carolina, also founded Balanced Pharma. According to Keadle, two of the most pressing patient concerns when it comes to dentistry is the failure of anesthesia and the fear of “the shot.”

Good dental care could help lower the risk of a second stroke, a recent study from UNC researchers found.

Balanced Pharma works to change the painful injection, the company website states. Put another way, “the shot matters,” the website notes.

A study conducted by the company that was published in Dentist Today found that more than 7 of every 10 dental patients would pay additional fees if the dentist used a faster, less painful local anesthetic.

The company says that multiple studies have shown that “pH-balanced local anesthetics provide improved comfort and much faster onset of anesthesia,” adding that 17 peer-reviewed studies “concluded that pH-balanced lidocaine with epinephrine demonstrated a significant improvement in injection comfort.”

The company’s website notes that its products are currently in development, and are not approved by FDA for sale or distribution.